Leadership & Pay ·
Tempest Therapeutics announced that Justin Trojanowski resigned as Principal Financial Officer and Principal…
TPSTTempest Therapeutics, Inc.
Tempest Therapeutics announced that Justin Trojanowski resigned as Principal Financial Officer and Principal Accounting Officer effective September 1, 2026. The Board appointed Nicholas Rossettos as Chief Financial Officer, Treasurer, and Corporate Secretary on the same date. Rossettos brings over 30 years of experience in biopharmaceutical finance, including prior roles at TransCode Therapeutics and Sernova Corp. This executive transition is material to investors as it involves key financial leadership changes. The company operates in the biotechnology industry.